"At Rao Dermatology, you will encounter a team of professionals dedicated to patient service of the highest calibre. Our staff is caring and compassionate to ALL of your dermatological issues, whether they be of medical and cosmetic in nature, regardless of severity. Every member of our friendly and professional team has been trained by, and operates under the direct supervision of our Founder and Medical Director, Dr. Jaggi Rao, a Board Certified Dermatologist who is a well-reputed educator, innovator, researcher, speaker and clinician. We are always looking to improve your experience"

During the past decade, Alberta DermaSurgery Centre conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alberta DermaSurgery Centre" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Aristea Therapeutics, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored and "Horizon Therapeutics Ireland DAC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alberta DermaSurgery Centre" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Alberta DermaSurgery Centre" are "Atopic Dermatitis" (4 trials), "Palmoplantar Pustulosis" (2 trials), "Dermatitis, Atopic" (1 trials), "Discoid Lupus Erythematosus" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Alberta DermaSurgery Centre" in a lesser frequency.

Most popular intervention types in "Alberta DermaSurgery Centre" are "Drug" (10 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abrocitinib 200 mg" (2 trials), "RIST4721" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alberta DermaSurgery Centre" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Alberta DermaSurgery Centre". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Alberta DermaSurgery Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Alberta DermaSurgery Centre, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".